Filter
11103
Filtered Results: 11103
Text search:
national
health
system
Featured
Recommendations
888
New Publications
2929
Language
Document type
No document type
6108
Studies & Reports
1998
Guidelines
1445
Manuals
561
Strategic & Response Plan
444
Fact sheets
190
Training Material
162
Situation Updates
114
Resource Platforms
29
Brochures
22
Infographics
19
Online Courses
9
App
1
Videos
1
Countries / Regions
India
475
Global
455
Kenya
314
Latin America and the Carribbean
241
Ethiopia
230
South Africa
227
Sierra Leone
217
Nepal
213
Uganda
199
Western and Central Europe
190
Nigeria
188
Liberia
185
Myanmar / Burma
171
Indonesia
162
Malawi
148
Africa
148
Rwanda
147
Bangladesh
145
Zambia
142
Tanzania
139
Brazil
138
Ghana
126
Syria
123
Ukraine
103
Mozambique
103
Philippines
93
Congo, Democratic Republic of
91
Venezuela
89
Namibia
84
Colombia
81
Paraguay
73
South Sudan
70
Lesotho
69
Haiti
68
Eastern Europe
68
Guinea
67
Zimbabwe
66
Cambodia
66
Senegal
65
Germany
65
South–East Asia Region
63
Argentina
59
Asia
52
Peru
51
Yemen
49
Botswana
48
West and Central Africa
46
East and Southern Africa
45
Burkina Faso
43
Russia
43
Middle East and North Africa
40
Chile
36
Afghanistan
36
Eastern Europe and Central Asia
36
Cameroon
35
Pakistan
34
Ecuador
33
Benin
32
Eswatini/ Swaziland
31
Bolivia
28
Angola
27
Madagascar
27
Central African Republic
24
Jordan
23
Lebanon
23
Thailand
22
Western Pacific Region
22
Sudan
22
Somalia
22
Vietnam
19
China
17
USA
17
Mali
17
Tajikistan
16
Turkey
14
Albania
14
Guinea-Bissau
14
Moldova
14
Iraq
14
El Salvador
13
Laos
13
North America
11
Spain
11
Côte d’Ivoire / Ivory Coast
11
Sri Lanka
11
Papua New Guinea
10
Georgia
10
Mexico
9
Palestine
9
North Macedonia
8
Togo
8
Iran
8
Egypt
8
Honduras
8
Guatemala
8
Kyrgyzstan
7
Burundi
7
Portugal
7
Greece
7
Libya
7
Armenia
6
Jamaica
6
United Kingdom
6
Southern Africa
6
Romania
6
Poland
6
Chad
6
Timor Leste/ East Timor
5
Serbia
5
Kazakhstan
5
Dominican Republic
5
Hungary
5
Turkmenistan
5
Nicaragua
5
Gambia
4
Canada
4
Fiji
4
Singapore
4
Uzbekistan
4
Bhutan
4
Estonia
3
Niger
3
Malaysia
3
Vanuatu
3
Mongolia
3
Croatia
3
Saudi Arabia
3
Uruguay
3
Japan
3
Mauritius
3
Bosnia and Herzegovina
3
Djibouti
3
North Korea
2
Switzerland
2
Morocco
2
Qatar
2
Bulgaria
2
Italy
2
Lithuania
2
Ireland
2
Tunisia
2
Azerbaijan
2
Belarus
2
Israel
2
Slovakia
2
Solomon Islands
2
Australia
1
Mauritania
1
Gabon
1
Denmark
1
Belgium
1
France
1
Maldives
1
Norway
1
South Korea
1
Latvia
1
Cuba
1
Authors & Publishers
Publication Years
Category
Countries
4580
Clinical Guidelines
706
Key Resources
640
Public Health
567
Women & Child Health
493
Capacity Building
163
Pharmacy & Technologies
121
Annual Report MEDBOX
1
Toolboxes
COVID-19
1013
Mental Health
785
HIV
717
TB
586
Planetary Health
436
Disability
380
Rapid Response
331
AMR
310
NTDs
302
Conflict
299
Ebola & Marburg
291
Caregiver
284
Refugee
214
Pharmacy
207
Global Health Education
191
NCDs
172
Health Financing Toolbox
157
Natural Hazards
150
Zika
75
Specific Hazards
64
Cholera
60
Polio
55
Social Ethics
39
Malaria
22
Typhoon
10
South Sudan
2
However, very little is known about the trend of the quality of life over
time in untreated PLWHA compared to treated patients.
Exploring quality of life trends in treated and untreated
patients will help the health care system develop adapted
strategies to better manage the PLWHA in low-income
...
Noncommunicable diseases (NCDs) are the principal cause of morbidity, disability and premature mortality in Azerbaijan. The most effective way to reduce the NCD burden is to prevent NCD development, by addressing thebehavioural risk factors underlying NCDs at the population and individual leve...
Estimating the size of key affected populations (KAP) provides important data for planning and implementing an effective response to the HIV epidemic. In the Philippines, these KAP include males who have sex with males (MSM), female sex workers (FSW), and injecting drug users (IDU). Given the diffic...
The "Questions and Answers on Prevention and control of Alcohol related harm" has been developed by WHO country office in Viet Nam with technical contribution from national and international experts in the field. This publication provides scientific evidences on harms of alcohol use to the health of...
The main objectives of these guidelines are to:
1. contribute to the quality assurance of medicinal plant materials used as the source for herbal medicines to improve the quality, safety and efficacy of finished herbal products; 2. guide the formulation of national and/or regional GACP guideli...
1. contribute to the quality assurance of medicinal plant materials used as the source for herbal medicines to improve the quality, safety and efficacy of finished herbal products; 2. guide the formulation of national and/or regional GACP guideli...
Birth defect has been an emerging major cause of child mortality in the region. Scarcity of the birth defects information hampers policy decisions and control measures at national level. In order to create evidence for action for birth defects prevention in the region, WHO-SEARO in collaboration wit...
This short document summarizes the key content of the WHO report Reducing the harm from alcohol by regulating cross-border alcohol marketing, advertising and promotion. It outlines the way that alcohol is being marketed across national borders – often by digital means – and often regardless of t...
This document builds on the Background document prepared for the September 4-5, 2014 Consultation. It includes proposed elements to consider during the development of a framework to assist decision-making at global and national level.
The aim of the document is to assist Member States and releva...
The GAP articulates five objectives for tackling AMR, and sets out the tasks required to achieve them, highlighting
roles and responsibilities for country governments, the One Health Tripartite organizations (FAO, OIE and WHO) and other national and international partners. To ensure that all stakeh...
The WHO Guidance for Conducting a Country COVID-19 Intra-Action Review (IAR) was developed to guide countries to conduct periodic review(s) of their national and subnational COVID-19 response, so countries do not miss critical opportunities for learning and improvement to better respond to the COVID...
Since 1996, trachoma has been targeted for elimination as a public health problem worldwide. The active trachoma criterion for national elimination as a public health problem is a TF1–9 < 5%, sustained for at least two years in the absence of antibiotic mass drug administration (MDA), in each form...
Following the publication of Guidelines on certification of elimination of human onchocerciasis in 2001 by the World Health Organization (WHO), these are the first evidence-based guidelines developed by NTD Department according to the international standards. They provide a set of recommendations th...
Multidrug-resistant tuberculosis (MDR-TB) and extensively drug-resistant
tuberculosis (XDR-TB) increasingly occur in resource-constrained settings.
In the context of a national response to MDR- and XDR-TB, health workers in
TB clinics (in district hospitals and some accredited health centres) wil...
This first edition of our national neonatal care clinical guidelines is an initiative that aims to ensure that all the neonates in the Kingdom of Eswatini are offered standard, best quality of care and the best possible start in life. The guidelines have been formulated from various global sources a...
The WHO Regional Office for Europe has established the Childhood Obesity Surveillance Initiative in more than half thecountries in the Region for routine monitoring of the policy response to the emerging obesity epidemic. The aim of the system is to measure trends in overweight and obesity in childr...
Birth defect has been an emerging major cause of child mortality in the region. Scarcity of the birth defects information hampers policy decisions and control measures at national level. In order to create evidence for action for birth defects prevention in the region, WHO-SEARO in collaboration wit...
A survey was conducted in countries in all six WHO regions and focused on the building blocks that are considered prerequisites to combat antimicrobial resistance: a comprehensive national plan, laboratory capacity to undertake surveillance for resistant microorganisms, access to safe, effective ant...
This guidance is intended to be used by programme managers following the decision to introduce human papillomavirus (HPV) virological testing as a screening assay in their national cervical cancer prevention and control programme. The guidance includes a step-by-step process to be followed after the...
The WHO European Office for the Prevention and Control of Noncommunicable Diseases organized an expert meeting on monitoring of digital marketing of unhealthy products to children and adolescents in June 2018. Based on that meeting, this report aims to provide a tool to support Member States in moni...
The document "Priority medical devices list for the COVID-19 response and associated technical specifications" complements this guideline.
This document provides interim guidance on the quality, performance characteristics and related standards of personal protective equipment (PPE) to be used i...
